Cetuximab for the treatment of colorectal cancer by Jonker Derek J, O'Callaghan Chris J, Karapetis Christos S, Zalcberg John R, Tu Dongsheng, Au Heather-Jane, Berry Scott R, Krahn Marianne, Price Timothy, Simes R John, Tebbutt Niall C, van Hazel Guy, Wierzbicki Rafal, Langer Christiane, Moore Malcolm J in The New England journal of medicine (2007).

[PMID: 18003960] PubMed


Cetuximab, an IgG1 chimeric monoclonal antibody against epidermal growth factor receptor (EGFR), has activity against colorectal cancers that express EGFR.

[ hide abstract ]

Discussed In Paper


Rx Annotations

No dosing information annotated.